Induction chemotherapy followed by camrelizumab plus apatinib and chemotherapy demonstrates promising antitumor activity with acceptable safety as first-line treatment for extensive-stage small-cell lung cancer: A multicenter, single-arm trial
Peer-Reviewed Publication